Product Specification
Host |
Mouse |
Antigen |
CD28 |
Synonyms |
T-cell-specific surface glycoprotein CD28; TP44 |
Location |
Cell membrane |
Accession |
P10747 |
Clone Number |
S-R495 |
Antibody Type |
Mouse mAb |
Isotype |
IgG1 |
Application |
FCM |
Reactivity |
Hu |
Positive Sample |
human PBMC |
Purification |
Protein G |
Concentration |
0.2mg/ml |
Conjugation |
Alexa Fluor® 488 |
Physical Appearance |
Liquid |
Storage Buffer |
PBS, 25% Glycerol, 1% BSA, 0.3% Proclin 300 |
Stability & Storage |
12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
application |
dilution |
species |
FCM |
5 μl per million cells in 100μl volume |
Hu |
Background
CD28 is a critical costimulatory receptor expressed on the surface of T cells, playing a pivotal role in T cell activation, proliferation, and differentiation. It is a type I transmembrane glycoprotein that forms homodimers and interacts with its ligands CD80 (B7-1) and CD86 (B7-2), which are primarily found on antigen-presenting cells. The engagement of CD28 with these ligands provides a secondary signal necessary for full T cell activation, which complements the primary signal generated by the T cell receptor (TCR) engagement with the antigen-presenting MHC molecule. This costimulation is essential for preventing T cell anergy and inducing robust immune responses. CD28 signaling activates various downstream pathways, including the PI3K-AKT pathway, which is important for cell survival and metabolism. It also upregulates the expression of IL-2 and its receptor, leading to T cell proliferation. Furthermore, CD28 has been implicated in the generation and maintenance of regulatory T cells (Tregs), and its expression levels can vary in different T cell subsets, including a decrease in expression on highly differentiated effector T cells. The importance of CD28 in immune responses is underscored by the immune defects observed in CD28-deficient mice, which include impaired T cell help for B cells and poor memory T cell responses.